Results for Fourth Quarter and Financial Year ended March 31, 2026
MAXHEALTH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Max Healthcare reported strong FY26 results with consolidated revenue growing 19.1% year-over-year to ₹8,37,345 lakhs. Profit after tax surged 34.1% to ₹1,44,241 lakhs, driven by the merger of Crosslay Remedies with Jaypee Healthcare (completed December 2025) which resulted in a cumulative tax benefit of ₹14,148 lakhs. EPS improved to ₹14.83 from ₹11.07. Exceptional items of ₹4,824 lakhs include ₹3,390 lakhs impact from new Labour Codes. The company also completed acquisition of 58.28% stake in Kalinga Hospitals (May 2026) for ₹29,797 lakhs and approved construction of a new 712-bed hospital in Lucknow. Auditors issued an unmodified (clean) opinion.
The 34% PAT growth significantly exceeds the 25% benchmark and signals strong operational performance. However, expansion investments (Lucknow hospital, Kalinga acquisition) and higher labour costs may compress margins near-term. The clean audit opinion removes key risks. Shareholders can expect dividend of ₹2 per share subject to AGM approval.